Literature DB >> 26277367

Depression in people with coronary heart disease: prognostic significance and mechanisms.

Chris Dickens1.   

Abstract

Depression affects about 40 % of people with coronary heart disease (CHD). This group with depression and CHD have increased mortality and morbidity, worse health-related quality of life, use health services more frequently and consequently cost the health service and the national economy considerably more than their non-depressed counterparts. A number of characteristics of depression and plausible mechanisms have been proposed to explain this observed association, which could lead to improved understanding of the association and lead to new interventions to improve cardiac outcomes. This review summarises the evidence linking depression with worse cardiac outcomes, considers specific aspects of depression which may predict worse outcomes and reviews the mechanisms that could potentially explain the direct or indirect association of depression with coronary outcomes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26277367     DOI: 10.1007/s11886-015-0640-6

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  104 in total

1.  Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment.

Authors:  Marcus W Agelink; Cavit Boz; Heiko Ullrich; Jürgen Andrich
Journal:  Psychiatry Res       Date:  2002-12-15       Impact factor: 3.222

2.  Genetic predictors of depressive symptoms in cardiac patients.

Authors:  Jeanne M McCaffery; Qing Ling Duan; Nancy Frasure-Smith; Amina Barhdadi; Francois Lespérance; Pierre Théroux; Guy A Rouleau; Marie-Pierre Dubé
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

3.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

4.  Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemia.

Authors:  Thomas Rutledge; Tanya S Kenkre; Diane V Thompson; Vera A Bittner; Kerry Whittaker; Jo-Ann Eastwood; Wafia Eteiba; Carol E Cornell; David S Krantz; Carl J Pepine; B Delia Johnson; Eileen M Handberg; C Noel Bairey Merz
Journal:  Am J Med       Date:  2014-04-24       Impact factor: 4.965

5.  Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment.

Authors:  Stavroula Beratis; Aggeliki Katrivanou; Sophia Georgiou; Alexandra Monastirli; Efstathia Pasmatzi; Philippos Gourzis; Dionysios Tsambaos
Journal:  J Psychosom Res       Date:  2005-01       Impact factor: 3.006

6.  Somatic/affective symptoms, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12-month all-cause mortality.

Authors:  Annelieke M Roest; Brett D Thombs; Sherry L Grace; Donna E Stewart; Susan E Abbey; Peter de Jonge
Journal:  J Affect Disord       Date:  2010-12-14       Impact factor: 4.839

7.  Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events.

Authors:  Peter de Jonge; Rob H S van den Brink; Titia A Spijkerman; Johan Ormel
Journal:  J Am Coll Cardiol       Date:  2006-11-09       Impact factor: 24.094

Review 8.  Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood.

Authors:  Katherine M Appleton; Peter J Rogers; Andrew R Ness
Journal:  Am J Clin Nutr       Date:  2010-02-03       Impact factor: 7.045

9.  Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.

Authors:  Peter de Jonge; Adriaan Honig; Joost P van Melle; Aart H Schene; Astrid M G Kuyper; Dorien Tulner; Annique Schins; Johan Ormel
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112

10.  Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study.

Authors:  Marjolein H Kamphuis; Mirjam I Geerlings; Jacqueline M Dekker; Simona Giampaoli; Aulikki Nissinen; Diederick E Grobbee; Daan Kromhout
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-12
View more
  12 in total

Review 1.  Psychological interventions for coronary heart disease.

Authors:  Suzanne H Richards; Lindsey Anderson; Caroline E Jenkinson; Ben Whalley; Karen Rees; Philippa Davies; Paul Bennett; Zulian Liu; Robert West; David R Thompson; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2017-04-28

2.  Pretreatment with Ginseng Fruit Saponins Affects Serotonin Expression in an Experimental Comorbidity Model of Myocardial Infarction and Depression.

Authors:  Mei-Yan Liu; Yan-Ping Ren; Li-Jun Zhang; Jamie Y Ding
Journal:  Aging Dis       Date:  2016-12-01       Impact factor: 6.745

3.  Pre-surgical depression and anxiety and recovery following coronary artery bypass graft surgery.

Authors:  Lydia Poole; Amy Ronaldson; Tara Kidd; Elizabeth Leigh; Marjan Jahangiri; Andrew Steptoe
Journal:  J Behav Med       Date:  2016-08-23

4.  Effectiveness and safety of modified 'Huoxue Shugan' formulas on coronary heart disease combined with depression: protocol for a systematic review.

Authors:  Mingtai Chen; Ling Men; Lijun Ou; Tao Li; Meihuan Li; Xiaoling Zhong; Jian Zhang; Zhong Zhang
Journal:  BMJ Open       Date:  2018-11-03       Impact factor: 2.692

5.  Somatic and sociodemographic predictors of depression outcome among depressed patients with coronary artery disease - a secondary analysis of the SPIRR-CAD study.

Authors:  Frank Vitinius; Steffen Escherich; Hans-Christian Deter; Martin Hellmich; Jana Jünger; Katja Petrowski; Karl-Heinz Ladwig; Frank Lambertus; Matthias Michal; Cora Weber; Martina de Zwaan; Christoph Herrmann-Lingen; Joram Ronel; Christian Albus
Journal:  BMC Psychiatry       Date:  2019-02-04       Impact factor: 3.630

6.  Randomized Trial of Mindfulness-Based Stress Reduction in Cardiac Patients Eligible for Cardiac Rehabilitation.

Authors:  Prabhjot S Nijjar; John E Connett; Ruth Lindquist; Roland Brown; Marsha Burt; Aaron Pergolski; Alexandra Wolfe; Priya Balaji; Nitya Chandiramani; Xiaohui Yu; Mary Jo Kreitzer; Susan A Everson-Rose
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

7.  Assessing the effectiveness of enhanced psychological care for patients with depressive symptoms attending cardiac rehabilitation compared with treatment as usual (CADENCE): study protocol for a pilot cluster randomised controlled trial.

Authors:  Suzanne H Richards; Chris Dickens; Rob Anderson; David A Richards; Rod S Taylor; Obioha C Ukoumunne; David Kessler; Katrina Turner; Willem Kuyken; Manish Gandhi; Luke Knight; Andrew Gibson; Antoinette Davey; Fiona Warren; Rachel Winder; Christine Wright; John Campbell
Journal:  Trials       Date:  2016-02-02       Impact factor: 2.279

8.  Patients' and nurses' views on providing psychological support within cardiac rehabilitation programmes: a qualitative study.

Authors:  Katrina M Turner; Rachel Winder; John L Campbell; David A Richards; Manish Gandhi; Chris M Dickens; Suzanne Richards
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

9.  Assessing the effectiveness of Enhanced Psychological Care for patients with depressive symptoms attending cardiac rehabilitation compared with treatment as usual (CADENCE): a pilot cluster randomised controlled trial.

Authors:  Suzanne H Richards; Chris Dickens; Rob Anderson; David A Richards; Rod S Taylor; Obioha C Ukoumunne; Katrina M Turner; Manish Gandhi; Willem Kuyken; Andrew Gibson; Antoinette Davey; Fiona Warren; Rachel Winder; John Campbell
Journal:  Trials       Date:  2018-04-02       Impact factor: 2.279

10.  Association of FKBP5 polymorphisms with patient susceptibility to coronary artery disease comorbid with depression.

Authors:  Haidong Wang; Chao Wang; Xingfa Song; Hai Liu; Yun Zhang; Pei Jiang
Journal:  PeerJ       Date:  2020-06-03       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.